Phreesia (PHR) 10-Q 8 Sep 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2022	Sep. 02, 2022
Entity Addresses [Line Items]
Amendment Flag	false
Entity Central Index Key	0001412408
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--01-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-38977
Entity Registrant Name	PHREESIA, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2275479
City Area Code	888
Local Phone Number	654-7473
Entity Address, Address Line One	1521 Concord Pike
Entity Address, Address Line Two	Suite 301 PMB 221
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19803
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	PHR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		52,532,170
Former Address
Entity Addresses [Line Items]
Entity Address, Address Line One	434 Fayetteville St
Entity Address, Address Line Two	Suite 1400
Entity Address, City or Town	Raleigh
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27601

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current:
Cash and cash equivalents	$ 240,729	$ 313,812
Settlement assets	19,725	19,590
Accounts receivable, net of allowance for doubtful accounts of $1,029 and $863 as of July 31, 2022 and January 31, 2022, respectively	46,958	40,262
Deferred contract acquisition costs	1,363	1,642
Prepaid expenses and other current assets	7,721	11,043
Total current assets	316,496	386,349
Property and equipment, net of accumulated depreciation and amortization of $61,661 and $53,321 as of July 31, 2022 and January 31, 2022, respectively	28,558	34,645
Capitalized internal-use software, net of accumulated amortization of $33,809 and $31,139 as of July 31, 2022 and January 31, 2022, respectively	27,522	17,643
Operating lease right-of-use assets	1,315	2,337
Deferred contract acquisition costs	1,988	2,437
Intangible assets, net of accumulated amortization of $1,864 and $1,178 as of July 31, 2022 and January 31, 2022, respectively	12,086	12,772
Deferred tax asset	75	515
Goodwill	33,836	33,621
Other assets	4,112	4,157
Total Assets	425,988	494,476
Current:
Settlement obligations	19,725	19,590
Current portion of finance lease liabilities and other debt	5,717	5,821
Current portion of operating lease liabilities	1,298	1,281
Accounts payable	10,088	5,119
Accrued expenses	17,925	20,128
Deferred revenue	17,195	16,493
Total current liabilities	71,948	68,432
Long-term finance lease liabilities and other debt	4,933	7,423
Operating lease liabilities, non-current	633	1,276
Long-term deferred revenue	10	65
Total Liabilities	77,524	77,196
Commitments and contingencies (Note 11)
Stockholders’ Equity:
Common stock, $0.01 par value - 500,000,000 shares authorized as of both July 31, 2022 and January 31, 2022; 53,072,838 and 52,095,964 shares issued as of July 31, 2022 and January 31, 2022, respectively	531	521
Additional paid-in capital	896,264	860,657
Accumulated deficit	(527,896)	(429,938)
Treasury stock, at cost, 563,428 and 301,003 shares as of July 31, 2022 and January 31, 2022, respectively	(20,435)	(13,960)
Total Stockholders’ Equity	348,464	417,280
Total Liabilities and Stockholders’ Equity	$ 425,988	$ 494,476

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,029	$ 863
Accumulated depreciation and amortization, property and equipment	61,661	53,321
Accumulated amortization, capitalized internal-use software	33,809	31,139
Accumulated amortization, intangible assets	$ 1,864	$ 1,178
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, issued (in shares)	53,072,838	52,095,964
Treasury stock (in shares)	563,428	301,003

Unaudited Consolidated Statemen

Unaudited Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue:
Total revenues	$ 67,867	$ 51,007	$ 131,221	$ 99,298
Expenses:
Cost of revenue (excluding depreciation and amortization)	14,873	10,032	29,259	18,566
Payment processing expense	12,554	9,648	24,712	19,373
Sales and marketing	38,341	22,167	78,372	37,179
Research and development	22,542	11,443	43,177	19,497
General and administrative	20,073	16,244	40,928	28,915
Depreciation	4,220	3,701	8,498	6,998
Amortization	1,599	1,580	3,203	3,231
Total expenses	114,202	74,815	228,149	133,759
Operating loss	(46,335)	(23,808)	(96,928)	(34,461)
Other income (expense), net	38	(90)	7	(24)
Interest (expense) income, net	(206)	(207)	(589)	(445)
Total other expense, net	(168)	(297)	(582)	(469)
Loss before provision for income taxes	(46,503)	(24,105)	(97,510)	(34,930)
Provision for income taxes	(213)	(288)	(448)	(437)
Net loss	$ (46,716)	$ (24,393)	$ (97,958)	$ (35,367)
Net loss per share attributable to common stockholders - basic (in dollars per share)	$ (0.89)	$ (0.48)	$ (1.88)	$ (0.73)
Net loss per share attributable to common stockholders - diluted (in dollars per share)	$ (0.89)	$ (0.48)	$ (1.88)	$ (0.73)
Weighted-average common shares outstanding - basic (in shares)	52,325,209	50,577,614	52,135,250	48,287,305
Weighted-average common shares outstanding - diluted (in shares)	52,325,209	50,577,614	52,135,250	48,287,305
Subscription and related services
Revenue:
Total revenues	$ 31,069	$ 22,885	$ 60,170	$ 44,704
Payment processing fees
Revenue:
Total revenues	19,581	16,306	38,962	32,950
Life sciences
Revenue:
Total revenues	$ 17,217	$ 11,816	$ 32,089	$ 21,644

Unaudited Consolidated Statem_2

Unaudited Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	APIC	Accumulated Deficit	Treasury stock
Beginning balance (in shares) at Jan. 31, 2021		44,880,883
Beginning balance at Jan. 31, 2021	$ 263,306	$ 449	$ 579,599	$ (311,777)	$ (4,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,974)			(10,974)
Stock-based compensation	5,774		5,774
Exercise of stock options and vesting of restricted stock units (in shares)		214,346
Exercise of stock options and vesting of restricted stock units	500	$ 2	498
Treasury stock from vesting of restricted stock units - satisfaction of tax withholdings	(1,145)				(1,145)
Issuance of common stock in follow-on public offering, net (in shares)		5,175,000
Issuance of common stock in follow-on public offering, net	245,813	$ 52	245,761
Ending balance (in shares) at Apr. 30, 2021		50,270,229
Ending balance at Apr. 30, 2021	503,274	$ 503	831,632	(322,751)	(6,110)
Beginning balance (in shares) at Jan. 31, 2021		44,880,883
Beginning balance at Jan. 31, 2021	263,306	$ 449	579,599	(311,777)	(4,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35,367)
Ending balance (in shares) at Jul. 31, 2021		50,892,126
Ending balance at Jul. 31, 2021	486,564	$ 509	840,287	(347,144)	(7,088)
Beginning balance (in shares) at Apr. 30, 2021		50,270,229
Beginning balance at Apr. 30, 2021	503,274	$ 503	831,632	(322,751)	(6,110)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(24,393)			(24,393)
Stock-based compensation	7,355		7,355
Exercise of stock options and vesting of restricted stock units (in shares)		621,897
Exercise of stock options and vesting of restricted stock units	1,306	$ 6	1,300
Treasury stock from vesting of restricted stock units - satisfaction of tax withholdings	(978)				(978)
Ending balance (in shares) at Jul. 31, 2021		50,892,126
Ending balance at Jul. 31, 2021	486,564	$ 509	840,287	(347,144)	(7,088)
Beginning balance (in shares) at Jan. 31, 2022		52,095,964
Beginning balance at Jan. 31, 2022	417,280	$ 521	860,657	(429,938)	(13,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(51,242)			(51,242)
Stock-based compensation	12,594		12,594
Exercise of stock options and vesting of restricted stock units (in shares)		326,624
Exercise of stock options and vesting of restricted stock units	548	$ 4	544
Issuance of stock to settle bonus liabilities (in shares)		233,135
Issuance of stock for share-settled bonus awards	6,774	$ 2	6,772
Treasury stock from vesting of restricted stock units - satisfaction of tax withholdings	(4,735)				(4,735)
Ending balance (in shares) at Apr. 30, 2022		52,655,723
Ending balance at Apr. 30, 2022	381,219	$ 527	880,567	(481,180)	(18,695)
Beginning balance (in shares) at Jan. 31, 2022		52,095,964
Beginning balance at Jan. 31, 2022	417,280	$ 521	860,657	(429,938)	(13,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (97,958)
Exercise of stock options and vesting of restricted stock units (in shares)	201,415
Issuance of common stock for employee stock purchase plan	$ 2,040
Ending balance (in shares) at Jul. 31, 2022		53,072,838
Ending balance at Jul. 31, 2022	348,464	$ 531	896,264	(527,896)	(20,435)
Beginning balance (in shares) at Apr. 30, 2022		52,655,723
Beginning balance at Apr. 30, 2022	381,219	$ 527	880,567	(481,180)	(18,695)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(46,716)			(46,716)
Stock-based compensation	13,236		13,236
Exercise of stock options and vesting of restricted stock units (in shares)		321,148
Exercise of stock options and vesting of restricted stock units	425	$ 3	422
Issuance of common stock for employee stock purchase plan (in shares)		95,967
Issuance of common stock for employee stock purchase plan	2,040	$ 1	2,039
Treasury stock from vesting of restricted stock units - satisfaction of tax withholdings	(1,740)				(1,740)
Ending balance (in shares) at Jul. 31, 2022		53,072,838
Ending balance at Jul. 31, 2022	$ 348,464	$ 531	$ 896,264	$ (527,896)	$ (20,435)

Unaudited Consolidated Statem_3

Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Operating activities:
Net loss	$ (97,958)	$ (35,367)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	11,701	10,229
Stock-based compensation expense	28,709	13,047
Amortization of deferred financing costs and debt discount	144	144
Cost of Phreesia hardware purchased by customers	546	273
Deferred contract acquisition costs amortization	905	1,152
Non-cash operating lease expense	1,022	483
Change in fair value of contingent consideration liabilities	0	209
Deferred tax asset	440	279
Changes in operating assets and liabilities:
Accounts receivable	(6,696)	(1,304)
Prepaid expenses and other assets	3,190	(1,037)
Deferred contract acquisition costs	(177)	(2,541)
Accounts payable	3,715	950
Accrued expenses and other liabilities	983	(275)
Lease liability	(647)	(544)
Deferred revenue	647	2,100
Net cash used in operating activities	(53,476)	(12,202)
Investing activities:
Capitalized internal-use software	(10,242)	(5,023)
Purchases of property and equipment	(2,634)	(5,030)
Net cash used in investing activities	(12,876)	(10,053)
Financing activities:
Proceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions	0	245,813
Proceeds from issuance of common stock upon exercise of stock options	1,141	2,678
Treasury stock to satisfy tax withholdings on stock compensation awards	(6,309)	(1,960)
Proceeds from employee stock purchase plan	1,949	295
Finance lease payments	(2,899)	(2,100)
Principal payments on financing agreements	(216)	(873)
Debt issuance costs and loan facility fee payments	(397)	(125)
Payment of contingent consideration for acquisitions	0	(400)
Net cash (used in) provided by financing activities	(6,731)	243,328
Net (decrease) increase in cash and cash equivalents	(73,083)	221,073
Cash and cash equivalents – beginning of period	313,812	218,781
Cash and cash equivalents – end of period	240,729	439,854
Supplemental information of non-cash investing and financing information:
Right-of-use assets recorded in exchange for operating lease liabilities	0	81
Property and equipment acquisitions through finance leases	526	1,980
Purchase of property and equipment and capitalized software included in accounts payable	2,379	3,503
Capitalized stock-based compensation	695	82
Issuance of stock to settle liabilities for stock-based compensation	8,814	0
Cash paid for:
Interest	$ 446	$ 365

Background and liquidity

Background and liquidity	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and liquidity	Background and liquidity (a) Background Phreesia, Inc. (the "Company") is a leading provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through the SaaS-based technology platform (the "Phreesia Platform" or "Platform"), the Company offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments and clinical support. The Company’s Platform also provides life sciences companies, patient advocacy, public interest and other not-for-profit organizations with a channel for targeted and direct communication with patients. In connection with the patient intake and registration process, Phreesia offers its healthcare services clients the ability to lease tablets ("PhreesiaPads") and on-site kiosks ("Arrivals Kiosks") along with their monthly subscription. The Company was formed in May 2005. On September 8, 2022, the Company ceased using its Raleigh, North Carolina office as its principal executive offices. (b) Liquidity Since the Company commenced operations, it has not generated sufficient revenue to meet its operating expenses and has continued to incur significant net losses. To date, the Company has primarily relied upon the proceeds from issuances of common stock, debt and preferred stock to fund its operations as well as sales of Company products and services in the normal course of business. Management believes that net losses and negative cash flows will continue for at least the next year. Management believes that the Company’s cash and cash equivalents at July 31, 2022, along with cash generated in the normal course of business, and available borrowing capacity under the Second Amended and Restated Loan and Security Agreement with Silicon Valley Bank ("SVB"), as amended by the First Loan Modification Agreement (as amended, the "Third SVB Facility") (Note 6), are sufficient to fund its operations for at least the next 12 months. The Company will seek to obtain additional financing, if needed, to successfully implement its long-term strategy.

Basis of presentation

Basis of presentation	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation (a) Consolidated financial statements The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and regulations of the Securities and Exchange Commission ("SEC") regarding quarterly financial reporting and include the accounts of Phreesia, Inc., its branch operation in Canada and its consolidated subsidiaries (or collectively, the "Company"). (b) Fiscal year The Company’s fiscal year ends on January 31. References to fiscal 2023 and 2022 refer to the fiscal years ending on January 31, 2023 and January 31, 2022, respectively. (c) Unaudited interim financial statements The accompanying unaudited interim consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s interim financial position as of July 31, 2022 and the results of its operations, changes in its stockholders' equity and its cash flows for the periods ended July 31, 2022 and 2021. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results for the interim periods are not necessarily indicative of results to be expected for the full year, any other interim periods, or any future year or period. The Company’s management believes that the

Summary of significant accounti

Summary of significant accounting policies	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Summary of significant accounting policies	Summary of significant accounting policies The Company’s significant accounting policies are disclosed in the audited financial statements for the fiscal year ended January 31, 2022. Since the date of those audited financial statements, there have been no material changes to the Company’s significant accounting policies, including the status of recent accounting pronouncements, other than those detailed below. The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments. Although management believes its estimates and assumptions are reasonable under the circumstances at the time they are made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Actual results could differ from those estimates made under different assumptions or circumstances. The most significant assumptions and estimates relate to the allowance for doubtful accounts, capitalized internal-use software, the determination of the useful lives of property and equipment, the fair value of securities underlying stock-based compensation, the fair value of identifiable assets and liabilities and contingent consideration in business acquisitions, and the realization of deferred tax assets. (b) Concentrations of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take one two The Company’s customers are primarily physician’s offices and other healthcare services organizations located in the United States as well as pharmaceutical companies. The Company did not have any individual customers that represented more than 10% of total revenues for both the three and six months ended July 31, 2022 and 2021. As of both July 31, 2022 and January 31, 2022, the Company had receivables from at least one entity that accounted for at least 10% of total accounts receivable. (c) Risks and uncertainties In March 2020, the World Health Organization declared the ongoing outbreak of a novel strain of coronavirus ("COVID-19") a pandemic. There continues to be uncertainty as to the duration and extent to which the global COVID-19 pandemic, as well as the emergence of new variants, may adversely impact the Company's business operations, financial performance, and results of operations, as well as macroeconomic conditions, at this time. Other Risks and Uncertainties The Company is subject to a variety of risk factors, including the economy, data privacy and security laws and government regulations. Additionally, the Company is subject to other risks associated with the markets in which it operates including reliance on third party vendors, partners, and service providers. Certain of the Company's service providers, including certain third-party software developers, are located in international locations subject to warfare and/or political and economic instability, such as Russia, Ukraine and India. As with any business, operation of the Company involves risk, including the risk of service interruption impacting the operations of the Company's business and the Company's customer’s facilities below expected levels of operation, shut downs due to the breakdown or failure of information technology and communications systems, changes in laws or regulations, political and economic instability, or catastrophic events such as fires, earthquakes, floods, explosions, global health concerns such as pandemics or other similar occurrences affecting the delivery of our productions and services. The occurrence of any of these events could significantly reduce or eliminate revenues generated, or significantly increase the expenses of the Company's operations, adversely impacting the Company’s operating results and the Company's ability to meet the Company's obligations and commitments. (d) New accounting pronouncements Impact of recently adopted accounting pronouncements During the three and six months ended July 31, 2022, the Company did not adopt any accounting pronouncements that materially impacted the Company's financial statements. Recent accounting pronouncements not yet adopted There are no recently issued accounting pronouncements the Company has not yet adopted that will materially impact the Company's consolidated financial statements.

Composition of certain financia

Composition of certain financial statement captions	6 Months Ended
	Jul. 31, 2022
Composition of Certain Financial Statements [Abstract]
Composition of certain financial statement captions	Composition of certain financial statement captions (a) Accrued expenses Accrued expenses as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Payroll-related expenses and taxes $ 6,771 $ 10,780 Payment processing fees liability 3,876 3,502 Tax liabilities 2,998 2,093 Information technology services 2,142 1,266 Other 2,138 2,487 Total $ 17,925 $ 20,128 (b) Property and equipment Property and equipment as of July 31, 2022 and January 31, 2022 are as follows: Useful Life (years) July 31, 2022 January 31, 2022 PhreesiaPads and Arrivals Kiosks 3 $ 26,835 $ 26,387 Computer equipment 3 55,519 53,957 Computer software 3 to 5 5,520 5,311 Hardware development 3 1,058 1,024 Furniture and fixtures 7 539 539 Leasehold improvements 2 748 748 Total property and equipment $ 90,219 $ 87,966 Less accumulated depreciation (61,661) (53,321) Property and equipment — net $ 28,558 $ 34,645 Depreciation expense related to property and equipment amounted to $4,220 and $3,701 for the three months ended July 31, 2022 and 2021, respectively. Depreciation expense related to property and equipment amounted to $8,498 and $6,998 for the six months ended July 31, 2022 and 2021, respectively. Assets acquired under finance leases included in computer equipment were $27,842 and $27,310 as of July 31, 2022 and January 31, 2022, respectively. Accumulated amortization of assets under finance leases was $17,896 and $15,025 as of July 31, 2022 and January 31, 2022, respectively. (c) Capitalized internal use software For the three months ended July 31, 2022 and 2021, the Company capitalized $5,970 and $2,526, respectively, of costs related to the Phreesia Platform. For the six months ended July 31, 2022 and 2021, the Company capitalized $12,395 and $4,798, respectively, of costs related to the Phreesia Platform. During the three months ended July 31, 2022 and 2021, amortization expense related to capitalized internal-use software was $1,255 and $1,452, respectively. During the six months ended July 31, 2022 and 2021, amortization expense related to capitalized internal-use software was $2,516 and $2,975, respectively. (d) Intangible assets and goodwill The following presents the details of intangible assets as of July 31, 2022 and January 31, 2022: Useful Life (years) July 31, 2022 January 31, 2022 Acquired technology 5 $ 1,410 $ 1,410 Customer relationship 7 to 10 6,340 6,340 License 15 6,200 6,200 Total intangible assets, gross carrying value $ 13,950 $ 13,950 Less accumulated amortization (1,864) (1,178) Net carrying value $ 12,086 $ 12,772 The remaining useful life for acquired technology in years was 3.1 and 3.5 as of July 31, 2022 and January 31, 2022, respectively. The remaining useful life for customer relationships in years was 8.7 and 9.2 as of July 31, 2022 and January 31, 2022, respectively. The remaining useful life for the license to the Patient Activation Measure ("PAM"®) in years was 14.4 and 14.8 as of July 31, 2022 and January 31, 2022, respectively. Amortization expense associated with intangible assets amounted to $344 and $128 for the three months ended July 31, 2022 and 2021, respectively. Amortization expense associated with intangible assets amounted to $687 and $256 for the six months ended July 31, 2022 and 2021, respectively. The estimated amortization expense for intangible assets for the next five years and thereafter is as follows as of July 31, 2022: July 31, 2022 2023 (Remaining six months) $ 686 Fiscal Years Ending January 31, 2024 1,358 2025 1,273 2026 1,242 2027 - thereafter 7,527 Total $ 12,086 There were no significant changes to the Company's goodwill balance during the six months ended July 31, 2022. The Company did not record any impairments of goodwill during the three and six months ended July 31, 2022 or 2021. Goodwill was $33,836 and $33,621 as of July 31, 2022 and January 31, 2022, respectively. (e) Accounts receivable Accounts receivable as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Billed $ 45,320 $ 40,733 Unbilled 2,667 392 Total accounts receivable, gross $ 47,987 $ 41,125 Less accounts receivable allowances (1,029) (863) Total accounts receivable $ 46,958 $ 40,262 Activity in the Company's allowance for doubtful accounts was as follows for the six months ended July 31, 2022: July 31, 2022 Balance, January 31, 2022 $ 863 Bad debt expense 317 Write-offs and adjustments (151) Balance, July 31, 2022 $ 1,029 The Company’s allowance for doubtful accounts represents the current estimate of expected future losses based on prior bad debt experience as well as considerations for specific customers as applicable. The Company's accounts receivable are considered past due when they are outstanding past the due date listed on the invoice to the customer. The Company writes off accounts receivable and removes the associated allowance for doubtful accounts when the Company deems the receivables to be uncollectible. (f) Prepaid and other current assets Prepaid and other current assets as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Prepaid software and business systems $ 3,036 $ 3,738 Prepaid data center expenses 2,711 3,230 Prepaid insurance 110 1,924 Other prepaid expenses and other current assets 1,864 2,151 Total prepaid and other current assets $ 7,721 $ 11,043 (g) Cloud computing implementation costs The Company enters into cloud computing service contracts to support its sales and marketing, product development and administrative activities. Subsequent to the adoption of ASU 2018-15 in May 2020, the Company capitalizes certain implementation costs for cloud computing arrangements that meet the definition of a service contract. The Company includes these capitalized implementation costs within Prepaid expenses and other current assets and within other assets on its consolidated balance sheets. Once placed in service, the Company amortizes these costs over the remaining subscription term to the same caption in the statements of operations as the related cloud subscription. Capitalized implementation costs for cloud computing arrangements accounted for as service contracts were $1,532 and $1,514 as of July 31, 2022 and January 31, 2022, respectively. Accumulated amortization of capitalized implementation costs for these arrangements was $403 and $199 as of July 31, 2022 and January 31, 2022, respectively. (h) Other income (expense), net Other income (expense), net for the three months ended July 31, 2022 and 2021 was income of $38 and expense of $90, respectively. Other income (expense), net for the six months ended July 31, 2022 and 2021 was income of $7 and expense of $24, respectively. For all periods presented, other income (expense), net was composed primarily of foreign exchange gains and losses.

Revenue and contract costs

Revenue and contract costs	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue and contract costs	Revenue and contract costs The Company generates revenue primarily from providing an integrated SaaS-based software and payment platform for the healthcare industry. The Company derives revenue from subscription fees and related services generated from the Company’s healthcare services clients for access to the Phreesia Platform, payment processing fees based on patient payment volume, and fees from life sciences companies to deliver marketing content to its patients using the Phreesia Platform. The amount of subscription and related services revenue recorded pursuant to ASC 842 for the leasing of the Company’s PhreesiaPads and Arrivals Kiosks was $2,482 and $1,579 for the three months ended July 31, 2022 and 2021, respectively. The amount of subscription and related services revenue recorded pursuant to ASC 842 for the leasing of the Company’s PhreesiaPads and Arrivals Kiosks was $4,974 and $3,223 for the six months ended July 31, 2022 and 2021, respectively. Contract balances The following table represents a roll-forward of contract assets: January 31, 2022 $ 392 Amount transferred to receivables from beginning balance of contract assets (340) Contract asset additions, net of reclassification to receivables 2,615 July 31, 2022 $ 2,667 The following table represents a roll-forward of deferred revenue: January 31, 2022 $ 16,558 Revenue recognized that was included in deferred revenue at the beginning of the period (13,015) Revenue recognized that was not included in deferred revenue at the beginning of the period (17,626) Increases due to invoicing prior to satisfaction of performance obligations 31,288 July 31, 2022 $ 17,205 Cost to obtain a contract The Company capitalizes certain incremental costs to obtain customer contracts and amortizes these costs over a period of benefit that the Company has estimated to be three The following table represents a roll forward of deferred contract acquisition costs: Beginning balance, January 31, 2022 $ 4,079 Additions to deferred contract acquisition costs 177 Amortization of deferred contract acquisition costs (905) Ending balance, July 31, 2022 3,351 Deferred contract acquisition costs, current (to be amortized in next 12 months) 1,363 Deferred contract acquisition costs, non-current 1,988 Total deferred contract acquisition costs $ 3,351

Finance leases and other debt

Finance leases and other debt	6 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
Finance leases and other debt	Finance leases and other debt As of July 31, 2022 and January 31, 2022, the Company had the following outstanding finance lease liabilities and other debt: July 31, 2022 January 31, 2022 Finance leases $ 10,492 $ 12,884 Financing arrangements 45 266 Accrued interest and payments 113 94 Total finance lease liabilities and other debt 10,650 13,244 Less - current portion of finance lease liabilities and other debt (5,717) (5,821) Long-term finance lease liabilities and other debt $ 4,933 $ 7,423 (a) Finance leases See Note 10 - Leases for more information regarding finance leases. (b) Amended and Restated Loan and Security Agreement On February 28, 2019 (the "Effective Date"), the Company entered into the Amended and Restated Loan and Security Agreement (the "First SVB Facility") that provided for a $20,000 term loan. In connection with the transaction, the Company recorded a $1,073 loss on extinguishment of debt within other (expense) income, net for the settlement of previously outstanding loans payable. On March 28, 2022 (the "Third SVB Effective Date"), the Company entered into a First Loan Modification Agreement to the Second SVB Facility (as amended, the "Third SVB Facility") to increase the borrowing capacity from $50,000 to $100,000 and to reduce the interest rate on the facility. Borrowings under the Third SVB Facility are payable on May 5, 2025. Borrowings under the Third SVB Facility bear interest, which is payable monthly, at a floating rate equal to the greater of 3.25% or the Wall Street Journal Prime Rate minus 0.5%. As of July 31, 2022, the interest rate on the Second SVB Facility was 5.00%. In addition to principal and interest due under the revolving credit facility, the Company is required to pay an annual commitment fee of approximately $250 per year and a quarterly fee of 0.15% per annum of the average unused revolving line under the facility. The Company had $100,000 of availability under the facility as of July 31, 2022. In the event that the Company terminates the Third SVB Facility prior to May 5, 2024, the Company will be required to pay a termination fee of up to 1.5% of borrowing capacity based on the length of time between termination and maturity. Any Company obligations under the Third SVB Facility are secured by a first priority security interest in substantially all of its assets, other than intellectual property. The Third SVB Facility includes a financial covenant that requires the Company to maintain a minimum Adjusted Quick Ratio as defined in the Third SVB Facility. The Third SVB Facility also includes a financial covenant that requires the Company to achieve certain profitability and liquidity thresholds. The financial covenant will not be effective if the Company maintains certain levels of liquidity as defined. Additionally, the Third SVB Facility contains customary events of default. The Company was in compliance with all covenants related to the Third SVB Facility as of July 31, 2022. The Company presents unamortized deferred costs within other assets. The Company is amortizing the remaining unamortized costs over the remaining term of the Third SVB Facility. Maturities of finance leases and other debt, in each of the next five years and thereafter are as follows: Total Finance Leases Other Debt 2023 (Remaining six months) $ 3,007 $ 2,894 $ 113 Fiscal year ending January 31: 2024 4,966 4,921 45 2025 2,475 2,475 — 2026 202 202 — 2027 — — — Total maturities of finance leases and other debt $ 10,650 $ 10,492 $ 158 The components of interest (expense) income, net are as follows: Three months ended Six months ended 2022 2021 2022 2021 Interest expense (1) $ (292) $ (226) $ (694) $ (484) Interest income 86 19 105 39 Interest (expense) income, net $ (206) $ (207) $ (589) $ (445) (1) Includes amortization of deferred financing costs and original issue discount.

Stockholders' equity

Stockholders' equity	6 Months Ended
	Jul. 31, 2022
Equity [Abstract]
Stockholders' equity	Stockholders' equity (a) Common stock The Company closed an IPO on July 22, 2019 and filed an Amended and Restated Certificate of Incorporation authorizing the issuance of up to 500,000,000 shares of common stock, par value $0.01 per share. On April 12, 2021, the Company completed a follow-on offering of its common stock. In connection with this offering, the Company issued and sold 5,175,000 shares of common stock at an issuance price of $50.00 per share resulting in net proceeds of $245,813, after deducting underwriting discounts and commissions. (b) Treasury stock The Company's equity-based compensation plan allows for the grant of non-vested stock options, restricted stock units ("RSUs") and total shareholder return ("TSR") performance-based stock units ("PSUs") to its employees pursuant to the terms of its stock option and incentive plans (see Note 8). Under the provision of the plans, for RSU and PSU awards, unless otherwise elected, participants fulfill their related income tax withholding obligation by having shares withheld at the time of vesting. On the date of vesting of the RSU or PSU, the Company divides the participant's estimated income tax obligation in dollars by the closing price of its common stock and withholds the resulting number of vested shares. The shares withheld are then transferred to the Company's treasury stock at cost.

Equity-based compensation

Equity-based compensation	6 Months Ended
	Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]
Equity-based compensation	Equity-based compensation (a) Equity award plans In January 2018, the Board of Directors adopted the Company’s 2018 Stock Option Plan (as amended, the "2018 Stock Option Plan") which provided for the issuance of options to purchase up to 3,048,490 shares of the Company’s common stock to officers, directors, employees, and consultants. The option exercise price per share is determined by the Board of Directors based on the estimated fair value of the Company’s common stock. In June 2019, the Board of Directors adopted the Company’s 2019 Stock Option and Incentive Plan (the "2019 Plan"), which replaced the 2018 Stock Option Plan upon the completion of the IPO. The 2019 Plan allows the Compensation Committee of the Board of Directors (the "Compensation Committee") to make equity-based incentive awards including stock options, RSUs and PSUs to the Company’s officers, employees, directors, and consultants. The initial reserve for the issuance of awards under this plan was 2,139,683 shares of common stock. The initial number of shares reserved and available for issuance automatically increased on February 1, 2020 and automatically increases each February 1 thereafter by 5% of the number of shares of common stock outstanding on the immediately preceding January 31 (or such lesser number of shares determined by the Compensation Committee). As the 2018 Stock Option Plan was replaced by the 2019 Plan, all grants of stock options, RSUs and PSUs during the six months ended July 31, 2022 were made pursuant to the 2019 Plan. In June 2019, the Board of Directors also adopted the Company’s 2019 Employee Stock Purchase Plan (the "ESPP"), which became effective immediately prior to the effectiveness of the registration statement for the Company’s initial public offering. The total shares of common stock initially reserved under the ESPP is limited to 855,873 shares. In August 2021, the Company amended its fiscal 2022 incentive bonus to allow eligible employees to elect to receive all or a portion of their fiscal 2022 year end incentive compensation in the form of immediately vested restricted stock units instead of cash. In February 2022, the Company amended its fiscal 2023 incentive bonus to allow eligible employees to elect to receive all or a portion of their fiscal 2023 incentive compensation in the form of immediately vested restricted stock units instead of cash. (b) Summary of stock-based compensation The following table sets forth stock-based compensation by type of award: Three months ended Six months ended 2022 2021 2022 2021 RSUs $ 10,752 $ 6,072 $ 20,701 $ 10,842 Liability awards 1,669 — 3,574 — PSUs 1,805 551 3,447 1,037 Stock options 358 632 874 1,150 ESPP 321 100 808 100 Total stock based compensation $ 14,905 $ 7,355 $ 29,404 $ 13,129 The following table sets forth the presentation of stock-based compensation in the Company's financial statements: Three months ended Six months ended 2022 2021 2022 2021 Stock-based compensation expense recorded to additional paid-in capital (1) $ 13,236 $ 7,355 $ 25,830 $ 13,129 Stock-based compensation expense recorded to accrued expenses 1,669 — 3,574 — Total stock-based compensation 14,905 7,355 29,404 13,129 Less stock-based compensation expense capitalized as internal-use software (347) (82) (695) (82) Stock-based compensation expense per consolidated statements of operations $ 14,558 $ 7,273 $ 28,709 $ 13,047 (1) Stock-based compensation included in the Company's consolidated statements of stockholders' equity is consistent with these amounts. (c) Restricted stock units The Company has issued restricted stock units to employees and independent directors that vest based on a time-based condition. For RSUs granted to employees prior to January 2021, pursuant to a time-based condition, 10% of the restricted stock units vest after one year, 20% vest after two years, 30% vest after three years and 40% vest after four years. The restricted stock units expire seven years from the grant date. During the year ended January 31, 2022, the Company modified the vesting of RSUs granted subsequent to January 1, 2021 for employees other than its named executive officers listed in its most recent proxy statement ("NEOs") and other members of its executive management team. Pursuant to the modified vesting schedule, RSUs granted after January 1, 2021 for employees other than NEOs and other members of its executive management team vest 6.25% each quarter over four years based on continued service. For NEOs and other members of the Company's executive management team, RSUs granted after January 1, 2022 vest 6.25% each quarter over four years based on continued service. Additionally, the Company provides certain employees the option to settle their incentive bonus in immediately vested RSUs. In April 2022, the Company issued 233,135 immediately vested RSUs to settle fiscal 2022 share settled bonus awards. The RSUs granted to settle bonus awards are included in RSUs granted and vested in the table below. See section (g) Liability awards below for additional information regarding share settled bonus awards. Restricted stock units Unvested, January 31, 2022 3,133,839 Granted in six months ended July 31, 2022 2,159,354 Vested (685,496) Forfeited and expired (273,699) Unvested, July 31, 2022 4,333,998 As of July 31, 2022, there is $119,896 remaining of total unrecognized compensation cost related to these awards. The total unrecognized costs are expected to be recognized over a weighted-average term of 3.0 years. (d) Stock options Options granted under the equity award plans have a maximum term of ten years and vest over a period determined by the Board of Directors (generally four years from the date of grant or the commencement of the grantee’s employment with the Company). Options generally vest 25% at the one-year anniversary of the grant date, after which point they generally vest pro rata on a monthly basis. Number of Weighted- Weighted- Aggregate Outstanding — January 31, 2022 1,705,150 $ 6.01 Granted in six months ended July 31, 2022 — $ — Exercised (201,415) $ 4.84 Forfeited and expired (7,418) $ 4.42 Outstanding and expected to vest — July 31, 2022 1,496,317 $ 6.17 5.49 $ 25,911 Exercisable — July 31, 2022 1,262,735 $ 5.73 5.28 $ 22,431 Amount vested in six months ended July 31, 2022 50,287 $ 9.27 The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s estimated stock price at the time of exercise and the exercise price, multiplied by the number of related in-the-money options) that would have been received by the option holders had they exercised their options at the end of the period. This amount changes based on the market value of the Company’s common stock. The total intrinsic value of options exercised for the six months ended July 31, 2022 and 2021 (based on the difference between the Company’s estimated stock price on the exercise date and the respective exercise price, multiplied by the number of options exercised), was $4,029 and $36,832, respectively. As of July 31, 2022, there is $662 of total unrecognized compensation cost related to stock options issued to employees that is expected to be recognized over a weighted-average term of 0.5 years. For the three and six months ended July 31, 2022, stock-based compensation expense for stock options includes $16 and $229 related to the modification of stock options, respectively. (e) TSR performance-based restricted stock units ("PSUs") The Company grants PSUs to certain members of its management team. PSUs vest over approximately three years from the grant date upon satisfaction of both time-based requirements and market targets based on Phreesia's TSR relative to the TSR of each member of the Russell 3000 Index (the "Peer Group"). Depending on the percentage level at which the market-based condition is satisfied, the number of shares vesting could be between 0% and 200% of the number of PSUs originally granted. To earn the target number of PSUs (which represents 100% of the number of PSUs granted), the Company must perform at the 60th percentile, with the maximum number of PSUs earned if the Company performed at least at the 90th percentile. If Phreesia's TSR for the performance period is negative, the maximum number of PSUs that can be earned will be capped at 100%. The Company estimated the fair value of the PSUs using a Monte Carlo Simulation model which projected TSR for Phreesia and each member of the Peer Group over the performance period. The Company recognizes the grant date fair value of PSUs as compensation expense over the vesting period. Market-based PSU activity for the six months ended July 31, 2022 are as follows: Performance stock units Outstanding, January 31, 2022 396,216 Granted in six months ended July 31, 2022 — Vested — Forfeited and expired (3,555) Outstanding, July 31, 2022 392,661 As of July 31, 2022, unrecognized compensation cost related to PSUs was $15,518, to be recognized on a straight-line basis over a weighted average term of 2.3 years, subject to the participants' continued employment with the Company. (f) Employee stock purchase plan The ESPP is a compensatory plan because it provides participants with terms that are more favorable than those offered to other holders of the Company's common stock. Employees purchase shares at the lesser of (1) 85% of the closing stock price on the first day of the offering period or (2) 85% of the closing stock price on the last day of the offering period. In the U.S., t he ESPP is structured as a qualified employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986. In July 2022, the Company issued 95,967 shares of common stock for the ESPP purchase period ended on June 30, 2022. In connection with this issuance, the Company recorded a $2,040 increase to common stock and additional paid-in capital within stockholders' equity. As of July 31, 2022, unrecognized compensation cost related to the ESPP was $616, to be recognized over the next five months. In August 2021, the Company amended its fiscal 2022 incentive bonus to allow eligible employees to elect to receive all or a portion of their fiscal 2022 year-end incentive compensation in the form of immediately vested restricted stock units instead of cash. In February 2022, the Company amended its fiscal 2023 incentive bonus to allow eligible employees to elect to receive all or a portion of their fiscal 2023 incentive compensation in the form of immediately vested restricted stock units instead of cash. Restricted stock units issued to settle liability awards are covered by the 2019 Plan. Share-settled bonus awards will be settled at a value equal to 115% of the bonuses converted. These share settled bonus awards vest based on the achievement of the Company’s predefined performance targets. As share-settled bonus awards will be settled in a variable number of shares, the Company classifies share settled bonus awards as liabilities within accrued expenses in the accompanying consolidated balance sheets until they are settled in shares and included in stockholders' equity. During the six months ended July 31, 2022, the Company settled $6,774 of fiscal 2022 share settled bonus awards by issuing 233,135 immediately vested RSUs. See (c) Restricted Stock Units above for additional discussion regarding RSUs.

Fair value measurements

Fair value measurements	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Fair value measurements	Fair value measurements Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of July 31, 2022 Money market mutual funds $ 197,706 $ — $ — $ 197,706 Total assets $ 197,706 $ — $ — $ 197,706 The following table presents information about the Company's assets and liabilities that are measured at fair value as of January 31, 2022 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of January 31, 2022 Money market mutual funds $ 197,601 $ — $ — $ 197,601 Total assets $ 197,601 $ — $ — $ 197,601 The carrying value of the Company’s short-term financial instruments, including accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. The carrying value of the Company's debt approximates fair value because the interest rates approximate market rates and the debt maturities are relatively short-term. The Company did not have any transfers of assets and liabilities between levels of the fair value measurement hierarchy during both the three and six months ended July 31, 2022 and 2021.

Leases

Leases	6 Months Ended
	Jul. 31, 2022
Leases [Abstract]
Leases	Leases (a) Phreesia as lessee The Company leases several office premises and third-party data center spaces in the U.S. and Canada under operating leases which expire on various dates through March 2027. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The Company has also entered into various finance lease arrangements for computer equipment. These agreements are typically for two For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of July 31, 2022, for operating leases, the weighted-average remaining lease term is 1.9 years and the weighted-average discount rate is 3.5%. As of July 31, 2022, for finance leases, the weighted-average remaining lease term is 2.0 years, and the weighted-average discount rate is 3.7%. The components of lease expense for the six months ended July 31, 2022 were as follows: July 31, 2022 Operating leases: Operating lease cost $ 1,031 Variable lease cost 32 Total operating lease cost $ 1,063 Finance leases: Amortization of right-of-use assets $ 2,871 Interest on lease liabilities 210 Total finance lease cost $ 3,081 During the three months ended July 31, 2022, the Company ceased using its office premises in Ottawa, Canada. Additionally, during the three months ended July 31, 2022, the Company decided to cease using its office premises in Raleigh, North Carolina and Portland, Oregon in September 2022 and April 2023, respectively. In connection with this decision, the Company shortened the useful lives of the related right of use assets to end on the cease use date for each lease. The financial impact of the change in useful lives of the related right of use assets was not significant. The following represents a schedule of maturing lease commitments for operating and finance leases as of July 31, 2022: July 31, 2022 Operating Finance Maturity of lease liabilities 2023 (remaining six months) $ 682 $ 3,000 Fiscal year ending January 31, 2024 960 5,102 2025 225 2,566 2026 86 209 Thereafter 42 — Total future minimum lease payments $ 1,995 $ 10,877 Less: interest (64) (385) Present value of lease liabilities $ 1,931 $ 10,492 Other supplemental cash flow information for the six months ended July 31, 2022 was as follows: July 31, 2022 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 667 Operating cash used for finance leases 230 Financing cash used for finance leases 2,899 Total $ 3,796 Right-of-use assets obtained in exchange for lease liabilities: Operating $ — Finance 526 Total $ 526 (b) Phreesia as lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrivals Kiosks along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and six months ended July 31, 2022, the Company recognized $2,482 and $4,974, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrivals Kiosks.
Leases	Leases (a) Phreesia as lessee The Company leases several office premises and third-party data center spaces in the U.S. and Canada under operating leases which expire on various dates through March 2027. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The Company has also entered into various finance lease arrangements for computer equipment. These agreements are typically for two For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of July 31, 2022, for operating leases, the weighted-average remaining lease term is 1.9 years and the weighted-average discount rate is 3.5%. As of July 31, 2022, for finance leases, the weighted-average remaining lease term is 2.0 years, and the weighted-average discount rate is 3.7%. The components of lease expense for the six months ended July 31, 2022 were as follows: July 31, 2022 Operating leases: Operating lease cost $ 1,031 Variable lease cost 32 Total operating lease cost $ 1,063 Finance leases: Amortization of right-of-use assets $ 2,871 Interest on lease liabilities 210 Total finance lease cost $ 3,081 During the three months ended July 31, 2022, the Company ceased using its office premises in Ottawa, Canada. Additionally, during the three months ended July 31, 2022, the Company decided to cease using its office premises in Raleigh, North Carolina and Portland, Oregon in September 2022 and April 2023, respectively. In connection with this decision, the Company shortened the useful lives of the related right of use assets to end on the cease use date for each lease. The financial impact of the change in useful lives of the related right of use assets was not significant. The following represents a schedule of maturing lease commitments for operating and finance leases as of July 31, 2022: July 31, 2022 Operating Finance Maturity of lease liabilities 2023 (remaining six months) $ 682 $ 3,000 Fiscal year ending January 31, 2024 960 5,102 2025 225 2,566 2026 86 209 Thereafter 42 — Total future minimum lease payments $ 1,995 $ 10,877 Less: interest (64) (385) Present value of lease liabilities $ 1,931 $ 10,492 Other supplemental cash flow information for the six months ended July 31, 2022 was as follows: July 31, 2022 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 667 Operating cash used for finance leases 230 Financing cash used for finance leases 2,899 Total $ 3,796 Right-of-use assets obtained in exchange for lease liabilities: Operating $ — Finance 526 Total $ 526 (b) Phreesia as lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrivals Kiosks along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and six months ended July 31, 2022, the Company recognized $2,482 and $4,974, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrivals Kiosks.
Leases	Leases (a) Phreesia as lessee The Company leases several office premises and third-party data center spaces in the U.S. and Canada under operating leases which expire on various dates through March 2027. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The Company has also entered into various finance lease arrangements for computer equipment. These agreements are typically for two For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of July 31, 2022, for operating leases, the weighted-average remaining lease term is 1.9 years and the weighted-average discount rate is 3.5%. As of July 31, 2022, for finance leases, the weighted-average remaining lease term is 2.0 years, and the weighted-average discount rate is 3.7%. The components of lease expense for the six months ended July 31, 2022 were as follows: July 31, 2022 Operating leases: Operating lease cost $ 1,031 Variable lease cost 32 Total operating lease cost $ 1,063 Finance leases: Amortization of right-of-use assets $ 2,871 Interest on lease liabilities 210 Total finance lease cost $ 3,081 During the three months ended July 31, 2022, the Company ceased using its office premises in Ottawa, Canada. Additionally, during the three months ended July 31, 2022, the Company decided to cease using its office premises in Raleigh, North Carolina and Portland, Oregon in September 2022 and April 2023, respectively. In connection with this decision, the Company shortened the useful lives of the related right of use assets to end on the cease use date for each lease. The financial impact of the change in useful lives of the related right of use assets was not significant. The following represents a schedule of maturing lease commitments for operating and finance leases as of July 31, 2022: July 31, 2022 Operating Finance Maturity of lease liabilities 2023 (remaining six months) $ 682 $ 3,000 Fiscal year ending January 31, 2024 960 5,102 2025 225 2,566 2026 86 209 Thereafter 42 — Total future minimum lease payments $ 1,995 $ 10,877 Less: interest (64) (385) Present value of lease liabilities $ 1,931 $ 10,492 Other supplemental cash flow information for the six months ended July 31, 2022 was as follows: July 31, 2022 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 667 Operating cash used for finance leases 230 Financing cash used for finance leases 2,899 Total $ 3,796 Right-of-use assets obtained in exchange for lease liabilities: Operating $ — Finance 526 Total $ 526 (b) Phreesia as lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrivals Kiosks along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and six months ended July 31, 2022, the Company recognized $2,482 and $4,974, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrivals Kiosks.

Commitments and contingencies

Commitments and contingencies	6 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies (a) Indemnifications The Company’s agreements with certain customers include certain provisions for indemnifying customers against liabilities if its services infringe a third party’s intellectual property rights. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances that may be involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such provisions and have not accrued a ny liabilities related to such obligations in its consolidated financial statements. In addition, the Company has indemnification agreements with its directors and its executive officers that require it, among other things, to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of those persons in any action or proceedi n g to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by us, arising out of that person’s services as a director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable it to recover a portion of any future indemnification amounts paid. To date, there have been no claims under any of its directors and executive officers indemnification provisions. (b) Legal proceedings In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes or claims. Although the Company cannot predict with assurance the outcome of any litigation, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on its financial condition, results of operations or cash flows.

Income taxes

Income taxes	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income taxes	Income taxes For the three and six months ended July 31, 2022, the Company recorded a tax provision of $213 and $448, respectively, compared to a tax provision of $288 and $437, respectively, for the corresponding periods in the prior year. The Company's provision for income taxes was 0.5% and 1.3% of loss before income taxes for the six months ended July 31, 2022 and 2021, respectively. The Company's effective tax rate differs from the U.S. statutory tax rate of 21% primarily because the Company records a valuation allowance against the majority of its deferred tax assets, as well as deferred tax expense related to the use of net operating loss carry forwards attributable to the Company’s Canadian branch.Deferred tax assets and deferred tax liabilities are recognized based on temporary differences between the financial reporting and tax basis of assets and liabilities using statutory rates. Management of the Company has evaluated the positive and negative evidence pertaining to the realizability of its deferred tax assets, including the Company’s history of losses, and concluded that it is more likely than not that the Company will not recognize the benefits for the majority of its deferred tax assets. On the basis of this evaluation, the Company has recorded a valuation allowance against its deferred tax assets that are not more likely than not to be realized at both July 31, 2022 and January 31, 2022

Net loss per share attributable

Net loss per share attributable to common stockholders	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Net loss per share attributable to common stockholders	Net loss per share attributable to common stockholders(a) Net loss per share attributable to common stockholders Basic and diluted net loss per share attributable to common stockholders was calculated as follows: Three months ended Six months ended 2022 2021 2022 2021 Numerator: Net loss $ (46,716) $ (24,393) $ (97,958) $ (35,367) Denominator: Weighted-average shares of common stock outstanding, basic and diluted 52,325,209 50,577,614 52,135,250 48,287,305 Net loss per share attributable to common stockholders $ (0.89) $ (0.48) $ (1.88) $ (0.73) (b) Potential dilutive securities The Company’s potential dilutive securities, which include stock options, restricted stock units, performance stock units and grants under our employee stock purchase plan, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect: As of July 31, 2022 2021 Stock options to purchase common stock, restricted stock units and performance stock units 6,623,285 5,181,284 Employee stock purchase plan 76,634 34,850 Total 6,699,919 5,216,134

Related party transactions

Related party transactions	6 Months Ended
	Jul. 31, 2022
Related Party Transactions [Abstract]
Related party transactions	Related party transactions For the three months ended July 31, 2022 and 2021, the Company recognized revenue totaling $197 and $129, respectively, for advertisements placed by a pharmaceutical company, respectively. For the six months ended July 31, 2022 and 2021, the Company recognized revenue totaling $351 and $232, respectively. One of the Company's independent members of its board of directors serves on the board of directors for this pharmaceutical company. As of July 31, 2022 and January 31, 2022, accounts receivable from the pharmaceutical company totaled approximately $108 and $173, respectively. For the three and six months ended July 31, 2022, the Company recognized general and administrative expenses totaling $77 and $220 for software agreements with a software company, respectively. One of the Company's independent members of its board of directors serves as the chief executive officer and on the board of directors for this software company. As of July 31, 2022 and January 31, 2022, prepaid expenses and other current assets include approximately $206 and $374 of payments to this software company, respectively. As of January 31, 2022, other assets include $51 of payments to this software company. This software company has been a related party since October 2021 when this software company's chief executive officer and board member became an independent member of the Company's board of directors.

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Consolidated financial statements	Consolidated financial statementsThe accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and regulations of the Securities and Exchange Commission ("SEC") regarding quarterly financial reporting and include the accounts of Phreesia, Inc., its branch operation in Canada and its consolidated subsidiaries (or collectively, the "Company").
Fiscal year	Fiscal yearThe Company’s fiscal year ends on January 31. References to fiscal 2023 and 2022 refer to the fiscal years ending on January 31, 2023 and January 31, 2022, respectively.
Use of estimates	Use of estimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments. Although management believes its estimates and assumptions are reasonable under the circumstances at the time they are made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Actual results could differ from those estimates made under different assumptions or circumstances. The most significant assumptions and estimates relate to the allowance for doubtful accounts, capitalized internal-use software, the determination of the useful lives of property and equipment, the fair value of securities underlying stock-based compensation, the fair value of identifiable assets and liabilities and contingent consideration in business acquisitions, and the realization of deferred tax assets.
Concentrations of credit risk	Concentrations of credit riskFinancial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take one two
New accounting pronouncements	New accounting pronouncements Impact of recently adopted accounting pronouncements During the three and six months ended July 31, 2022, the Company did not adopt any accounting pronouncements that materially impacted the Company's financial statements. Recent accounting pronouncements not yet adopted There are no recently issued accounting pronouncements the Company has not yet adopted that will materially impact the Company's consolidated financial statements.

Composition of certain financ_2

Composition of certain financial statement captions (Tables)	6 Months Ended
	Jul. 31, 2022
Composition of Certain Financial Statements [Abstract]
Schedule of accrued expenses	Accrued expenses as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Payroll-related expenses and taxes $ 6,771 $ 10,780 Payment processing fees liability 3,876 3,502 Tax liabilities 2,998 2,093 Information technology services 2,142 1,266 Other 2,138 2,487 Total $ 17,925 $ 20,128
Schedule of property and equipment	Property and equipment as of July 31, 2022 and January 31, 2022 are as follows: Useful Life (years) July 31, 2022 January 31, 2022 PhreesiaPads and Arrivals Kiosks 3 $ 26,835 $ 26,387 Computer equipment 3 55,519 53,957 Computer software 3 to 5 5,520 5,311 Hardware development 3 1,058 1,024 Furniture and fixtures 7 539 539 Leasehold improvements 2 748 748 Total property and equipment $ 90,219 $ 87,966 Less accumulated depreciation (61,661) (53,321) Property and equipment — net $ 28,558 $ 34,645
Schedule of intangible assets	The following presents the details of intangible assets as of July 31, 2022 and January 31, 2022: Useful Life (years) July 31, 2022 January 31, 2022 Acquired technology 5 $ 1,410 $ 1,410 Customer relationship 7 to 10 6,340 6,340 License 15 6,200 6,200 Total intangible assets, gross carrying value $ 13,950 $ 13,950 Less accumulated amortization (1,864) (1,178) Net carrying value $ 12,086 $ 12,772
Schedule of estimated amortization expense for intangible assets	The estimated amortization expense for intangible assets for the next five years and thereafter is as follows as of July 31, 2022: July 31, 2022 2023 (Remaining six months) $ 686 Fiscal Years Ending January 31, 2024 1,358 2025 1,273 2026 1,242 2027 - thereafter 7,527 Total $ 12,086
Schedule of accounts receivable	Accounts receivable as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Billed $ 45,320 $ 40,733 Unbilled 2,667 392 Total accounts receivable, gross $ 47,987 $ 41,125 Less accounts receivable allowances (1,029) (863) Total accounts receivable $ 46,958 $ 40,262
Schedule of allowance for doubtful accounts	Activity in the Company's allowance for doubtful accounts was as follows for the six months ended July 31, 2022: July 31, 2022 Balance, January 31, 2022 $ 863 Bad debt expense 317 Write-offs and adjustments (151) Balance, July 31, 2022 $ 1,029
Schedule of prepaid and other current assets	Prepaid and other current assets as of July 31, 2022 and January 31, 2022 are as follows: July 31, 2022 January 31, 2022 Prepaid software and business systems $ 3,036 $ 3,738 Prepaid data center expenses 2,711 3,230 Prepaid insurance 110 1,924 Other prepaid expenses and other current assets 1,864 2,151 Total prepaid and other current assets $ 7,721 $ 11,043

Revenue and contract costs (Tab

Revenue and contract costs (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of rollforward of contract assets and contract liabilities	The following table represents a roll-forward of contract assets: January 31, 2022 $ 392 Amount transferred to receivables from beginning balance of contract assets (340) Contract asset additions, net of reclassification to receivables 2,615 July 31, 2022 $ 2,667 The following table represents a roll-forward of deferred revenue: January 31, 2022 $ 16,558 Revenue recognized that was included in deferred revenue at the beginning of the period (13,015) Revenue recognized that was not included in deferred revenue at the beginning of the period (17,626) Increases due to invoicing prior to satisfaction of performance obligations 31,288 July 31, 2022 $ 17,205
Schedule of deferred contract acquisition costs	The following table represents a roll forward of deferred contract acquisition costs: Beginning balance, January 31, 2022 $ 4,079 Additions to deferred contract acquisition costs 177 Amortization of deferred contract acquisition costs (905) Ending balance, July 31, 2022 3,351 Deferred contract acquisition costs, current (to be amortized in next 12 months) 1,363 Deferred contract acquisition costs, non-current 1,988 Total deferred contract acquisition costs $ 3,351

Finance leases and other debt (

Finance leases and other debt (Tables)	6 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
Schedule of long-term debt instruments	As of July 31, 2022 and January 31, 2022, the Company had the following outstanding finance lease liabilities and other debt: July 31, 2022 January 31, 2022 Finance leases $ 10,492 $ 12,884 Financing arrangements 45 266 Accrued interest and payments 113 94 Total finance lease liabilities and other debt 10,650 13,244 Less - current portion of finance lease liabilities and other debt (5,717) (5,821) Long-term finance lease liabilities and other debt $ 4,933 $ 7,423
Schedule of maturities of long-term debt	Maturities of finance leases and other debt, in each of the next five years and thereafter are as follows: Total Finance Leases Other Debt 2023 (Remaining six months) $ 3,007 $ 2,894 $ 113 Fiscal year ending January 31: 2024 4,966 4,921 45 2025 2,475 2,475 — 2026 202 202 — 2027 — — — Total maturities of finance leases and other debt $ 10,650 $ 10,492 $ 158
Schedule of interest income (expense), net	The components of interest (expense) income, net are as follows: Three months ended Six months ended 2022 2021 2022 2021 Interest expense (1) $ (292) $ (226) $ (694) $ (484) Interest income 86 19 105 39 Interest (expense) income, net $ (206) $ (207) $ (589) $ (445) (1) Includes amortization of deferred financing costs and original issue discount.

Equity-based compensation (Tabl

Equity-based compensation (Tables)	6 Months Ended
	Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of stock - based compensation by type of award	The following table sets forth stock-based compensation by type of award: Three months ended Six months ended 2022 2021 2022 2021 RSUs $ 10,752 $ 6,072 $ 20,701 $ 10,842 Liability awards 1,669 — 3,574 — PSUs 1,805 551 3,447 1,037 Stock options 358 632 874 1,150 ESPP 321 100 808 100 Total stock based compensation $ 14,905 $ 7,355 $ 29,404 $ 13,129
Schedule of stock-based compensation in financial statements	The following table sets forth the presentation of stock-based compensation in the Company's financial statements: Three months ended Six months ended 2022 2021 2022 2021 Stock-based compensation expense recorded to additional paid-in capital (1) $ 13,236 $ 7,355 $ 25,830 $ 13,129 Stock-based compensation expense recorded to accrued expenses 1,669 — 3,574 — Total stock-based compensation 14,905 7,355 29,404 13,129 Less stock-based compensation expense capitalized as internal-use software (347) (82) (695) (82) Stock-based compensation expense per consolidated statements of operations $ 14,558 $ 7,273 $ 28,709 $ 13,047 (1) Stock-based compensation included in the Company's consolidated statements of stockholders' equity is consistent with these amounts.
Schedule of restricted stock unit activity	Restricted stock units Unvested, January 31, 2022 3,133,839 Granted in six months ended July 31, 2022 2,159,354 Vested (685,496) Forfeited and expired (273,699) Unvested, July 31, 2022 4,333,998
Schedule of stock option activity	Number of Weighted- Weighted- Aggregate Outstanding — January 31, 2022 1,705,150 $ 6.01 Granted in six months ended July 31, 2022 — $ — Exercised (201,415) $ 4.84 Forfeited and expired (7,418) $ 4.42 Outstanding and expected to vest — July 31, 2022 1,496,317 $ 6.17 5.49 $ 25,911 Exercisable — July 31, 2022 1,262,735 $ 5.73 5.28 $ 22,431 Amount vested in six months ended July 31, 2022 50,287 $ 9.27
Schedule of market-based performance stock unit activity	Market-based PSU activity for the six months ended July 31, 2022 are as follows: Performance stock units Outstanding, January 31, 2022 396,216 Granted in six months ended July 31, 2022 — Vested — Forfeited and expired (3,555) Outstanding, July 31, 2022 392,661

Fair value measurements (Tables

Fair value measurements (Tables)	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value, assets and liabilities measured on recurring basis	Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of July 31, 2022 Money market mutual funds $ 197,706 $ — $ — $ 197,706 Total assets $ 197,706 $ — $ — $ 197,706 The following table presents information about the Company's assets and liabilities that are measured at fair value as of January 31, 2022 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of January 31, 2022 Money market mutual funds $ 197,601 $ — $ — $ 197,601 Total assets $ 197,601 $ — $ — $ 197,601

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2022
Leases [Abstract]
Schedule of lease expense and cash flow information	The components of lease expense for the six months ended July 31, 2022 were as follows: July 31, 2022 Operating leases: Operating lease cost $ 1,031 Variable lease cost 32 Total operating lease cost $ 1,063 Finance leases: Amortization of right-of-use assets $ 2,871 Interest on lease liabilities 210 Total finance lease cost $ 3,081 Other supplemental cash flow information for the six months ended July 31, 2022 was as follows: July 31, 2022 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 667 Operating cash used for finance leases 230 Financing cash used for finance leases 2,899 Total $ 3,796 Right-of-use assets obtained in exchange for lease liabilities: Operating $ — Finance 526 Total $ 526
Schedule of maturities of operating leases	The following represents a schedule of maturing lease commitments for operating and finance leases as of July 31, 2022: July 31, 2022 Operating Finance Maturity of lease liabilities 2023 (remaining six months) $ 682 $ 3,000 Fiscal year ending January 31, 2024 960 5,102 2025 225 2,566 2026 86 209 Thereafter 42 — Total future minimum lease payments $ 1,995 $ 10,877 Less: interest (64) (385) Present value of lease liabilities $ 1,931 $ 10,492
Schedule of maturities of finance leases	The following represents a schedule of maturing lease commitments for operating and finance leases as of July 31, 2022: July 31, 2022 Operating Finance Maturity of lease liabilities 2023 (remaining six months) $ 682 $ 3,000 Fiscal year ending January 31, 2024 960 5,102 2025 225 2,566 2026 86 209 Thereafter 42 — Total future minimum lease payments $ 1,995 $ 10,877 Less: interest (64) (385) Present value of lease liabilities $ 1,931 $ 10,492

Net loss per share attributab_2

Net loss per share attributable to common stockholders (Tables)	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Schedule of earnings per share, basic and diluted	Basic and diluted net loss per share attributable to common stockholders was calculated as follows: Three months ended Six months ended 2022 2021 2022 2021 Numerator: Net loss $ (46,716) $ (24,393) $ (97,958) $ (35,367) Denominator: Weighted-average shares of common stock outstanding, basic and diluted 52,325,209 50,577,614 52,135,250 48,287,305 Net loss per share attributable to common stockholders $ (0.89) $ (0.48) $ (1.88) $ (0.73)
Schedule of shares excluded from computation of diluted net loss per share	The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect: As of July 31, 2022 2021 Stock options to purchase common stock, restricted stock units and performance stock units 6,623,285 5,181,284 Employee stock purchase plan 76,634 34,850 Total 6,699,919 5,216,134

Background and liquidity (Detai

Background and liquidity (Details)	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of months the company have sufficient to fund its operations	12 months

Summary of significant accoun_3

Summary of significant accounting policies (Details) - processor	6 Months Ended	12 Months Ended
	Jul. 31, 2022	Jan. 31, 2022
Concentration Risk [Line Items]
Number of third-party payment processors	1
Minimum
Concentration Risk [Line Items]
Customer payment period	30 days
Settlement period (in days)	1 day
Minimum | Revenue Benchmark | Customer Concentration Risk | Customer One
Concentration Risk [Line Items]
Concentration risk (as a percent)	10%	10%
Maximum
Concentration Risk [Line Items]
Customer payment period	60 days
Settlement period (in days)	2 days

Composition of certain financ_3

Composition of certain financial statement captions - Accrued Expenses (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Composition of Certain Financial Statements [Abstract]
Payroll-related expenses and taxes	$ 6,771	$ 10,780
Payment processing fees liability	3,876	3,502
Tax liabilities	2,998	2,093
Information technology services	2,142	1,266
Other	2,138	2,487
Total	$ 17,925	$ 20,128

Composition of certain financ_4

Composition of certain financial statement captions - Property and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment	$ 90,219	$ 87,966
Less accumulated depreciation	(61,661)	(53,321)
Property and equipment — net	$ 28,558	34,645
PhreesiaPads and Arrivals Kiosks
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 26,835	26,387
Computer equipment
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 55,519	53,957
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment	$ 5,520	5,311
Computer software | Minimum
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Computer software | Maximum
Property, Plant and Equipment [Line Items]
Useful life (years)	5 years
Hardware development
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 1,058	1,024
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life (years)	7 years
Property and equipment	$ 539	539
Leasehold improvements
Property, Plant and Equipment [Line Items]
Useful life (years)	2 years
Property and equipment	$ 748	$ 748

Composition of certain financ_5

Composition of certain financial statement captions - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Composition of Certain Financial Statements [Line Items]
Depreciation	$ 4,220	$ 3,701	$ 8,498	$ 6,998
Capitalized cost of computer software	5,970	2,526	12,395	4,798
Capitalized computed software amortization	1,255	1,452	2,516	2,975
Amortization of intangible assets	344	128	687	256
Changes in goodwill balance			0
Goodwill, impairment loss	0	0	0	0
Goodwill	33,836		33,836		$ 33,621
Capitalized implementation costs	1,532		1,532		1,514
Capitalized implementation costs, accumulated amortization	403		403		$ 199
Other income (expense), net	38	$ (90)	$ 7	$ (24)
Acquired technology
Composition of Certain Financial Statements [Line Items]
Finite-lived intangible assets, remaining amortization period			3 years 1 month 6 days		3 years 6 months
Customer relationship
Composition of Certain Financial Statements [Line Items]
Finite-lived intangible assets, remaining amortization period			8 years 8 months 12 days		9 years 2 months 12 days
License
Composition of Certain Financial Statements [Line Items]
Finite-lived intangible assets, remaining amortization period			14 years 4 months 24 days		14 years 9 months 18 days
Computer equipment
Composition of Certain Financial Statements [Line Items]
Assets acquired under finance leases	27,842		$ 27,842		$ 27,310
Assets under finance lease, accumulated amortization	$ 17,896		$ 17,896		$ 15,025

Composition of certain financ_6

Composition of certain financial statement captions - Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 13,950	$ 13,950
Less accumulated amortization	(1,864)	(1,178)
Net carrying value	$ 12,086	12,772
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	5 years
Finite-lived intangibles	$ 1,410	1,410
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 6,340	6,340
Customer relationship | Minimum
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	7 years
Customer relationship | Maximum
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	10 years
License
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	15 years
Finite-lived intangibles	$ 6,200	$ 6,200

Composition of certain financ_7

Composition of certain financial statement captions - Finite-Lived Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Composition of Certain Financial Statements [Abstract]
2023 (Remaining six months)	$ 686
2024	1,358
2025	1,273
2026	1,242
2027 - thereafter	7,527
Net carrying value	$ 12,086	$ 12,772

Composition of certain financ_8

Composition of certain financial statement captions - Accounts Receivable (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Composition of Certain Financial Statements [Abstract]
Billed	$ 45,320	$ 40,733
Unbilled	2,667	392
Total accounts receivable, gross	47,987	41,125
Less accounts receivable allowances	(1,029)	(863)
Total accounts receivable	$ 46,958	$ 40,262

Composition of certain financ_9

Composition of certain financial statement captions - Allowance for Doubtful Accounts (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, January 31, 2022	$ 863
Bad debt expense	317
Write-offs and adjustments	(151)
Balance, July 31, 2022	$ 1,029

Composition of certain finan_10

Composition of certain financial statement captions - Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Composition of Certain Financial Statements [Abstract]
Prepaid software and business systems	$ 3,036	$ 3,738
Prepaid data center expenses	2,711	3,230
Prepaid insurance	110	1,924
Other prepaid expenses and other current assets	1,864	2,151
Total prepaid and other current assets	$ 7,721	$ 11,043

Revenue and contract costs - Na

Revenue and contract costs - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue from External Customer [Line Items]
Capitalized contract cost, amortization	$ 438	$ 577	$ 905	$ 1,152
Capitalized contract cost, impairment loss			$ 0	0
Minimum
Revenue from External Customer [Line Items]
Capitalized contract cost, amortization period	3 years		3 years
Maximum
Revenue from External Customer [Line Items]
Capitalized contract cost, amortization period	5 years		5 years
Subscription and Related Services
Revenue from External Customer [Line Items]
Lease income	$ 2,482	$ 1,579	$ 4,974	$ 3,223

Revenue and contract costs - Ro

Revenue and contract costs - Rollforward of Contract Assets and Liabilities (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Contract with Customer Asset [Roll Forward]
Beginning balance - Contract assets (unbilled accounts receivable)	$ 392
Amount transferred to receivables from beginning balance of contract assets	(340)
Contract asset additions, net of reclassification to receivables	2,615
Ending balance - Contract assets (unbilled accounts receivable)	2,667
Contract with Customer Liability [Roll Forward]
Beginning balance - Contract liabilities (deferred revenue)	16,558
Revenue recognized that was included in deferred revenue at the beginning of the period	(13,015)
Revenue recognized that was not included in deferred revenue at the beginning of the period	(17,626)
Increases due to invoicing prior to satisfaction of performance obligations	31,288
Ending balance - Contract liabilities (deferred revenue)	$ 17,205

Revenue and contract costs - De

Revenue and contract costs - Deferred contract acquisition costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Capitalized Contract Cost [Roll Forward]
Beginning balance, January 31, 2022			$ 4,079
Additions to deferred contract acquisition costs			177
Amortization of deferred contract acquisition costs	$ (438)	$ (577)	(905)	$ (1,152)
Ending balance, July 31, 2022	3,351		3,351
Deferred contract acquisition costs, current (to be amortized in next 12 months)	1,363		1,363		$ 1,642
Deferred contract acquisition costs, non-current	1,988		1,988		2,437
Total deferred contract acquisition costs	$ 3,351		$ 3,351		$ 4,079

Finance leases and other debt -

Finance leases and other debt - Outstanding Loan Balances (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Debt Instrument [Line Items]
Finance leases	$ 10,492	$ 12,884
Debt	158
Total finance lease liabilities and other debt	10,650	13,244
Less - current portion of finance lease liabilities and other debt	(5,717)	(5,821)
Long-term finance lease liabilities and other debt	4,933	7,423
Financing arrangements
Debt Instrument [Line Items]
Debt	45	266
Accrued interest and payments
Debt Instrument [Line Items]
Debt	$ 113	$ 94

Finance leases and other debt_2

Finance leases and other debt - Amended and Restated Loan and Security Agreement (Details) - USD ($)		6 Months Ended
	Feb. 28, 2019	Jul. 31, 2022	Mar. 28, 2022	Mar. 27, 2022	May 05, 2020
Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount	$ 20,000,000
Loss on extinguishment of debt	$ 1,073,000
Second SVB Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity					$ 50,000,000
Accordion feature, potential new maximum borrowing capacity					65,000,000
Long term debt					$ 20,663,000
Third SVB Facility
Debt Instrument [Line Items]
Effective interest rate (as a percent)		5%
Remaining borrowing capacity		$ 100,000,000
Third SVB Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 100,000,000	$ 50,000,000
Stated interest rate (as a percent)		3.25%
Annual fee amount		$ 250,000
Quarterly fee (as a percent)		0.15%
Termination fee percentage (up to) (as a percent)					1.50%
Third SVB Facility | Revolving Credit Facility | Prime Rate
Debt Instrument [Line Items]
Scheduled reduction in interest rate (as a percent)		0.50%

Finance leases and other debt_3

Finance leases and other debt - Long-Term Debt Maturities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Total
2023 (Remaining six months)	$ 3,007
2024	4,966
2025	2,475
2026	202
2027	0
Total maturities of finance leases and other debt	10,650
Finance Leases
2023 (Remaining six months)	2,894
2024	4,921
2025	2,475
2026	202
2027	0
Total finance leases	10,492	$ 12,884
Other Debt
2023 (Remaining six months)	113
2024	45
2025	0
2026	0
2027	0
Total other debt	$ 158

Finance leases and other debt_4

Finance leases and other debt - Interest Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Debt Disclosure [Abstract]
Interest expense	$ (292)	$ (226)	$ (694)	$ (484)
Interest income	86	19	105	39
Interest (expense) income, net	$ (206)	$ (207)	$ (589)	$ (445)

Stockholders' equity (Details)

Stockholders' equity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Apr. 12, 2021	Apr. 30, 2021	Jul. 31, 2022	Jan. 31, 2022	Jul. 22, 2019
Equity [Abstract]
Common stock, authorized (in shares)			500,000,000	500,000,000	500,000,000
Common stock, par value per share (in dollars per share)			$ 0.01	$ 0.01	$ 0.01
Issuance of common stock in public offering, net of issuance costs (in shares)	5,175,000
Issue price per share (in dollars per share)	$ 50
Issuance of common stock in follow-on public offering, net	$ 245,813	$ 245,813

Equity-based compensation - Nar

Equity-based compensation - Narrative (Details) $ in Thousands			1 Months Ended				3 Months Ended	6 Months Ended
	Jan. 01, 2021	Dec. 31, 2020	Jul. 31, 2022 USD ($) shares	Apr. 30, 2022 shares	Aug. 31, 2021	Jun. 30, 2019 shares	Jul. 31, 2022 USD ($) offering_period shares	Jul. 31, 2022 USD ($) shares	Jul. 31, 2021 USD ($)	Jan. 31, 2018 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value								$ 4,029	$ 36,832
Unrecognized compensation cost, stock options			$ 662				$ 662	662
Issuance of common stock for employee stock purchase plan (in shares) | shares			95,967
Issuance of common stock for employee stock purchase plan							$ 2,040	$ 2,040
Share settled bonuses			$ 6,774
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, employee common stock purchase discount (as a percent)							15%
Employee purchase price of common stock (as a percent)								85%
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares) | shares			640,742			855,873	640,742	640,742
Unrecognized compensation costs			$ 616				$ 616	$ 616
Weighted average remaining expense term								5 months
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term		7 years
Awards vested during period (in shares) | shares				233,135				685,496
Unrecognized compensation costs			119,896				119,896	$ 119,896
Weighted average remaining expense term								3 years
Bonus settlement in shares (as a percent)					115%
Restricted stock units | Employees Other than Named Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term	4 years
Quarterly vesting rate (as a percent)	6.25%
Restricted stock units | Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term	4 years
Quarterly vesting rate (as a percent)	6.25%
Restricted stock units | Share-based Payment Arrangement, Year 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)		10%
Vesting term		1 year
Restricted stock units | Share-based Payment Arrangement, Year 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)		20%
Vesting term		2 years
Restricted stock units | Share-based Payment Arrangement, Year 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)		30%
Vesting term		3 years
Restricted stock units | Share-based Payment Arrangement, Year 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)		40%
Vesting term		4 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term								4 years
Weighted average remaining expense term								6 months
Maximum term								10 years
Incremental stock-based compensation expense							16	$ 229
Performance stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								100%
Vesting term								3 years
Awards vested during period (in shares) | shares								0
Unrecognized compensation costs			$ 15,518				$ 15,518	$ 15,518
Weighted average remaining expense term								2 years 3 months 18 days
Performance stock units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								0%
Performance stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								200%
2018 Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for issuance (in shares) | shares										3,048,490
2019 Stock Option and Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserve for future issuance (in shares) | shares						2,139,683
Percentage increase in number of shares reserved (as a percent)						5%
Number of shares available for grant (in shares) | shares			3,780,626				3,780,626	3,780,626
2019 Stock Option and Incentive Plan | Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, number of offering periods per year | offering_period							2
ESPP offering period (in months)							6 months
2019 Stock Option and Incentive Plan | Stock options | Share-based Payment Arrangement, Year 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								25%
Vesting term								1 year
2019 Stock Option and Incentive Plan | Stock options | Share-based Payment Arrangement, Year 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								25%
Vesting term								1 year
2019 Stock Option and Incentive Plan | Stock options | Share-based Payment Arrangement, Year 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								25%
Vesting term								1 year
2019 Stock Option and Incentive Plan | Stock options | Share-based Payment Arrangement, Year 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rate (as a percent)								25%
Vesting term								1 year

Equity-based compensation - Sto

Equity-based compensation - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	$ 14,905	$ 7,355	$ 29,404	$ 13,129
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	10,752	6,072	20,701	10,842
Liability awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	1,669	0	3,574	0
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	1,805	551	3,447	1,037
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	358	632	874	1,150
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	$ 321	$ 100	$ 808	$ 100

Equity-based compensation - S_2

Equity-based compensation - Stock-based Compensation in the Financial Statements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	$ 14,905	$ 7,355	$ 29,404	$ 13,129
Less stock-based compensation expense capitalized as internal-use software	(347)	(82)	(695)	(82)
Stock-based compensation expense per consolidated statements of operations	14,558	7,273	28,709	13,047
Additional paid-in capital
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	13,236	7,355	25,830	13,129
Accrued expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock based compensation	$ 1,669	$ 0	$ 3,574	$ 0

Equity-based compensation - Res

Equity-based compensation - Restricted Stock Units and Performance Stock Units (Details) - shares	1 Months Ended	6 Months Ended
	Apr. 30, 2022	Jul. 31, 2022
Restricted stock units
Restricted Stock and Performance Stock Activity [Roll Forward]
Beginning balance (in shares)		3,133,839
Granted (in shares)		2,159,354
Vested (in shares)	(233,135)	(685,496)
Forfeited and expired (in shares)		(273,699)
Ending balance (in shares)		4,333,998
Performance stock units
Restricted Stock and Performance Stock Activity [Roll Forward]
Beginning balance (in shares)		396,216
Granted (in shares)		0
Vested (in shares)		0
Forfeited and expired (in shares)		(3,555)
Ending balance (in shares)		392,661

Equity-based compensation - S_3

Equity-based compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jul. 31, 2022
Number of options
Number of options outstanding, beginning (in shares)	1,705,150
Granted (in shares)	0
Exercised (in shares)	(201,415)
Forfeited and expired (in shares)	(7,418)
Number of options outstanding, ending (in shares)	1,496,317
Exercisable (in shares)	1,262,735
Amount vested during the period (in shares)	50,287
Weighted- average exercise price
Weighted- average exercise price outstanding, beginning balance (in dollars per share)	$ 6.01
Granted (in dollars per share)	0
Exercised (in dollars per share)	4.84
Forfeited and expired (in dollars per share)	4.42
Weighted- average exercise price outstanding, ending balance (in dollars per share)	6.17
Exercisable (in dollars per share)	5.73
Amount vested at the end of the period (in dollars per share)	$ 9.27
Outstanding and expected to vest- end of the period	5 years 5 months 26 days
Exercisable- end of period	5 years 3 months 10 days
Aggregate intrinsic value outstanding and expected to vest	$ 25,911
Aggregate intrinsic value exercisable	$ 22,431

Fair value measurements (Detail

Fair value measurements (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	$ 197,706	$ 197,601
Total assets	197,706	197,601
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	197,706	197,601
Total assets	197,706	197,601
Significant Other Observable Inputs (Level 2)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	0	0
Total assets	0	0
Significant Unobservable Inputs (Level 3)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	0	0
Total assets	$ 0	$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Lessee, Lease, Description [Line Items]
Operating lease, weighted average remaining lease term	1 year 10 months 24 days		1 year 10 months 24 days
Operating lease, weighted average discount rate (as a percent)	3.50%		3.50%
Finance lease, weighted average remaining lease term	2 years		2 years
Finance lease, weighted average discount rate (as a percent)	3.70%		3.70%
Subscription and Related Services
Lessee, Lease, Description [Line Items]
Lease income	$ 2,482	$ 1,579	$ 4,974	$ 3,223
Minimum | Computer equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	2 years		2 years
Maximum | Computer equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	3 years		3 years

Leases - Lease Expense (Details

Leases - Lease Expense (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Operating leases:
Operating lease cost	$ 1,031
Variable lease cost	32
Total operating lease cost	1,063
Finance leases:
Amortization of right-of-use assets	2,871
Interest on lease liabilities	210
Total finance lease cost	$ 3,081

Leases - Lease Liability Maturi

Leases - Lease Liability Maturity Schedule (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Operating
2023 (remaining six months)	$ 682
2024	960
2025	225
2026	86
Thereafter	42
Total future minimum lease payments	1,995
Less: interest	(64)
Present value of lease liabilities	1,931
Finance Leases
2023 (Remaining six months)	3,000
2024	5,102
2025	2,566
2026	209
Thereafter	0
Total future minimum lease payments	10,877
Less: interest	(385)
Present value of lease liabilities	$ 10,492	$ 12,884

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash used for operating leases	$ 667
Operating cash used for finance leases	230
Financing cash used for finance leases	2,899	$ 2,100
Total	3,796
Right-of-use assets obtained in exchange for lease liabilities:
Operating	0	$ 81
Finance	526
Total	$ 526

Income taxes (Details)

Income taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income tax provision (benefit)	$ 213	$ 288	$ 448	$ 437
Effective tax rate (as a percent)			0.50%	1.30%

Net loss per share attributab_3

Net loss per share attributable to common stockholders - Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2021	Apr. 30, 2021	Jul. 31, 2022	Jul. 31, 2021
Numerator:
Net loss	$ (46,716)	$ (51,242)	$ (24,393)	$ (10,974)	$ (97,958)	$ (35,367)
Denominator:
Weighted-average shares of common stock outstanding, basic (in shares)	52,325,209		50,577,614		52,135,250	48,287,305
Weighted-average shares of common stock outstanding, diluted (in shares)	52,325,209		50,577,614		52,135,250	48,287,305
Net loss per share attributable to common stockholders - basic (in dollars per share)	$ (0.89)		$ (0.48)		$ (1.88)	$ (0.73)
Net loss per share attributable to common stockholders - diluted (in dollars per share)	$ (0.89)		$ (0.48)		$ (1.88)	$ (0.73)

Net loss per share attributab_4

Net loss per share attributable to common stockholders - Antidilutive Securities Excluded from Computation of Earnings per Share (Details) - shares	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,699,919	5,216,134
Stock options to purchase common stock, restricted stock units and performance stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,623,285	5,181,284
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	76,634	34,850

Related party transactions (Det

Related party transactions (Details) - Affiliate of Director - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Advertisements with Pharmaceutical Company
Related Party Transaction [Line Items]
Recognized revenue from related parties	$ 197	$ 129	$ 351	$ 232
Accounts receivable from related parties	108		108		$ 173
Software Agreement
Related Party Transaction [Line Items]
General and administrative expenses from transactions with related party	77		220
Software Agreement | Prepaid and other current assets
Related Party Transaction [Line Items]
Due from related parties, current	$ 206		$ 206		374
Software Agreement | Other assets
Related Party Transaction [Line Items]
Due from related parties, noncurrent					$ 51